These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36921808)

  • 21. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?
    Cattaneo D; Fusi M; Cozzi V; Baldelli S; Bonini I; Gervasoni C; Clementi E
    Clin Pharmacokinet; 2021 May; 60(5):603-609. PubMed ID: 33180272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for linezolid-induced thrombocytopenia in adult inpatients.
    Han X; Wang J; Zan X; Peng L; Nie X
    Int J Clin Pharm; 2022 Apr; 44(2):330-338. PubMed ID: 34731363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.
    Zhang YM; Yu W; Zhou N; Li JZ; Xu LC; Xie ZY; Lu YF; Li LJ
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):287-92. PubMed ID: 26063030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
    Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
    J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.
    Takahashi Y; Takesue Y; Nakajima K; Ichiki K; Tsuchida T; Tatsumi S; Ishihara M; Ikeuchi H; Uchino M
    J Infect Chemother; 2011 Jun; 17(3):382-7. PubMed ID: 21127934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure.
    Liao R; Dong Y; Chen L; Wang T; Li H; Dong H
    Eur J Clin Pharmacol; 2023 Jan; 79(1):149-157. PubMed ID: 36434292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients.
    Ogami C; Tsuji Y; To H; Yamamoto Y
    J Infect Chemother; 2019 Dec; 25(12):979-986. PubMed ID: 31208925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of augmented renal clearance on the lower incidence of linezolid-related hematological toxicity.
    Sánchez-Sanz B; Caro-Teller JM; Gonzalez-Barrios I; Rodríguez-Quesada PP; Hernández-Ramos JA; Ferrari-Piquero JM
    Farm Hosp; 2023; 47(5):190-195. PubMed ID: 37394377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
    Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
    Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
    Fujii S; Takahashi S; Makino S; Kunimoto Y; Nakata H; Noda N; Sakurai K; Miyamoto A
    Chemotherapy; 2013; 59(5):319-24. PubMed ID: 24480883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical population pharmacokinetics and toxicodynamics of linezolid.
    Boak LM; Rayner CR; Grayson ML; Paterson DL; Spelman D; Khumra S; Capitano B; Forrest A; Li J; Nation RL; Bulitta JB
    Antimicrob Agents Chemother; 2014; 58(4):2334-43. PubMed ID: 24514086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients.
    Hsu YC; Chen SY; Hung YJ; Huang YW
    Sci Rep; 2022 Jun; 12(1):9894. PubMed ID: 35701469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.
    Zhou D; Shi T; Zhao S; Zhu J; Zhu L; Yang X; Xie W; Ye X
    J Clin Pharm Ther; 2020 Aug; 45(4):755-758. PubMed ID: 32403181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A risk factor-based predictive model for linezolid-induced anaemia: A 7-year retrospective study.
    Qin Y; Liu Y; Chen Z; Cao M; Shen Y; Ye Y
    J Clin Pharm Ther; 2021 Dec; 46(6):1591-1599. PubMed ID: 34287998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Translated article] Influence of augmented renal clearance in the lower incidence of linezolid-related haematological toxicity.
    Sánchez-Sanz B; Caro-Teller JM; González-Barrios I; Rodríguez-Quesada PP; Hernández-Ramos JA; Ferrari-Piquero JM
    Farm Hosp; 2023; 47(5):T190-T195. PubMed ID: 37679220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.